Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows
Medical male circumcision for HIV has benefits for women too
Demonstration projects explore the feasibility of PrEP for adolescents and young women in South Africa
Ipergay trial: PrEP still protected people who had less sex and used it less often
Another HIV vaccine efficacy trial will start this year
Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
90-90-90 progress in southern Africa: HIV testing gap needs to be closed in young people and men
Can self-testing engage 'hard-to-reach' men with HIV testing?
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show
